Clinical Trial Update: An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection [Phase 2]

View source ↗

Summary

Phase 2 exploratory study assessing safety, efficacy, and pharmacokinetics of intravenous DNV3837 in adults with Clostridium difficile infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• DNV3837

Snippet

Sponsor: Deinove | Conditions: Clostridium Difficile (C. Difficile) | Phase 2 | Status: UNKNOWN